BioVeritas
Biotechnology ResearchUnited States51-200 Employees
BioVeritas is redefining the future of SAF by unlocking more feedstocks and using less energy to deliver superior carbon intensity.
Innovation in SAF BioVeritas is actively developing and launching advanced sustainable aviation fuel processes, demonstrating strong innovation in biofuel technology. This positions them as a potential partner for companies seeking cutting-edge, eco-friendly fuel solutions.
Recent Facility Expansion The company's recent expansion of production and packaging facilities in Bryan, Texas indicates increased manufacturing capacity and capacity to meet growing demand, offering opportunities for supply chain and equipment vendors.
Leadership and Expertise Strategic hiring of senior executives in business development and operations reflects a focus on commercialization and growth, presenting opportunities for consulting, technology integration, and strategic partnership sales.
Strong Financial Position With revenue estimates between $50M and $100M and funding of $65M, BioVeritas shows robust financial health, likely enabling investment in new technologies, collaborations, and expanding market reach.
Market Engagement Active participation in industry events like TopSoil Summit 2025 signals industry engagement and thought leadership, creating avenues for networking and strategic alliances within the sustainable fuels ecosystem.
BioVeritas uses 8 technology products and services including MySQL, Webpack, Sentry, and more. Explore BioVeritas's tech stack below.
| BioVeritas Email Formats | Percentage |
| FLast@bioveritas.com | 50% |
| FLast@bioveritas.com | 50% |
Biotechnology ResearchUnited States51-200 Employees
BioVeritas is redefining the future of SAF by unlocking more feedstocks and using less energy to deliver superior carbon intensity.
BioVeritas has raised a total of $65M of funding over 1 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $65M.
BioVeritas's revenue is estimated to be in the range of $50M$100M
BioVeritas has raised a total of $65M of funding over 1 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $65M.
BioVeritas's revenue is estimated to be in the range of $50M$100M